Christopher Keenan
Investor Relations Contact at PLIANT THERAPEUTICS, INC.
Network origin in Christopher Keenan first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 30 | |
| Public Company | Pharmaceuticals: Major | 15 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Keenan via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal President Corporate Officer/Principal | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Director/Board Member Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| UCSF School of Pharmacy | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Treasurer | |
| MEDIVATION INC | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Synthekine, Inc.
 Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Biotechnology | Chief Executive Officer Human Resources Officer | |
Normunity, Inc.
 Normunity, Inc. Miscellaneous Commercial ServicesCommercial Services Normunity, Inc. is a biotechnology company that creates precision immuno-oncology medicines called immune normalizers. The company is based in West Haven, CT and has subsidiaries in the United States. These medicines target novel mechanisms that free the body's normal immunity against cancer. Normunity is based on an ongoing academic-biotech partnership with the lab of Dr. Lieping Chen at Yale School of Medicine. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. The CEO of the company is Rachel W. Humphrey. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor | |
Charcot-Marie-Tooth Association
 Charcot-Marie-Tooth Association Miscellaneous Commercial ServicesCommercial Services The Charcot-Marie-Tooth Association operates as a non-profit organization. The private company is based in Glenolden, PA. Suzanne Louise Bruhn has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| GERON CORPORATION | Biotechnology | Director/Board Member Chairman | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
Cardiovascular Research Institute
 Cardiovascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Cardiovascular Research Institute operates a cardiovascular research institute. The American company was founded by Alison Schecter. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| NEOGENOMICS, INC. | Medical/Nursing Services | General Counsel Director/Board Member | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| UCSF School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel General Counsel | |
Fonds D Investissement De La Culture Et Des Communications, LP
 Fonds D Investissement De La Culture Et Des Communications, LP Investment ManagersFinance Fonds D Investissement De La Culture Et Des Communications is an Independent Venture Capital firm founded in 1997.The firm is headquartered in Montréal. | Investment Managers | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| San Francisco State University | College/University | Undergraduate Degree | |
| Berkeley Law University of California | College/University | Graduate Degree | |
Orthobond Corp.
 Orthobond Corp. Chemicals: Major DiversifiedProcess Industries Orthobond Corp. develops chemicals to help facilitate better material surface bonding. It offers a technology based on self-assembled monolayers of phosphonate (SAMP) and osteoconductive self-assembled monolayer of phosphonate surface modification that elicits a biological response on inorganic implants without the use of a biologic. The company was founded by Gregory E. Lutz and Jeffery Schwartz in 2004 and is headquartered in North Brunswick, NJ. | Chemicals: Major Diversified | Chief Executive Officer | |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Actelion Pharmaceuticals US, Inc. is based in Titusville, NJ. Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes, and markets drugs. The CEO of the company is Samuele Butera. | Pharmaceuticals: Major | Human Resources Officer | |
| BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 47 |
| Switzerland | 2 |
| Ireland | 2 |
| Canada | 2 |
| Belgium | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 4 |
| Health Services | 2 |
Operational
| Director/Board Member | 202 |
| Corporate Officer/Principal | 121 |
| Independent Dir/Board Member | 79 |
| Undergraduate Degree | 39 |
| Chief Tech/Sci/R&D Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Elaine Jones | 37 |
| Neil Exter | 33 |
| Ho Young Huh | 32 |
| Charles Homcy | 29 |
| David Pyott | 27 |
| Gayle Crowell | 21 |
| Suzanne Bruhn | 18 |
| Halley Gilbert | 17 |
| Rachel Humphrey | 17 |
| Darren Cline | 15 |
| Bernard Coulie | 13 |
| Eric Lefebvre | 13 |
| Katharine Knobil | 12 |
| John Curnutte | 12 |
| Hong He | 11 |
- Stock Market
- Insiders
- Christopher Keenan
- Company connections
